中國人壽集團合併總資產突破6萬億人幣
內媒報道,中國人壽(02628.HK)母公司中國人壽集團上半年合併總資產超過6萬億元人民幣(下同),為經濟社會提供風險保障逾480萬億元,直接服務實體經濟存量投資規模逾3.6萬億元。
根據中國人壽集團2022年上半年工作會議,上半年集團經營穩中有進、穩中向好,穩的基礎得到鞏固,進的態勢開始顯現,重要指標優於同業,較好發揮行業穩發展的「壓艙石」作用。其中,保險板塊壽險公司內含價值穩居行業首位,財險公司保費增速持續高於行業平均和主要同業,養老險公司年金業務持續保持行業領先地位;投資板塊合併財務收益率高於行業平均水平;銀行板塊廣發銀行手續費淨收入按年增速排名股份制同業首位。
下半年集團將堅決落實「十四五」規劃推進實施方案,今年重點以體制機制改革固本培元,推動發展格局、營運效能與全面風險防控提檔升級,確保取得實質性成效。尤其是加快數碼化轉型,著力加強數據能力體系建設等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.